Chen SQ - Search Results

1

N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay.

Xia TL, Li X, Wang X, Zhu YJ, Zhang H, Cheng W, Chen ML, Ye Y, Li Y, Zhang A, Dai DL, Zhu QY, Yuan L, Zheng J, Huang H, Chen SQ, Xiao ZW, Wang HB, Roy G, Zhong Q, Lin D, Zeng YX, Wang J, Zhao B, Gewurz BE, Chen J, Zuo Z, Zeng MS. Xia TL, et al. Among authors: chen j, chen sq, chen ml. EMBO Rep. 2021 Apr 7;22(4):e50128. doi: 10.15252/embr.202050128. Epub 2021 Feb 19. EMBO Rep. 2021. PMID: 33605073 Free PMC article.

2

Tumor Cell-Secreted ISG15 Promotes Tumor Cell Migration and Immune Suppression by Inducing the Macrophage M2-Like Phenotype.

Chen RH, Xiao ZW, Yan XQ, Han P, Liang FY, Wang JY, Yu ST, Zhang TZ, Chen SQ, Zhong Q, Huang XM. Chen RH, et al. Among authors: chen sq. Front Immunol. 2020 Dec 23;11:594775. doi: 10.3389/fimmu.2020.594775. eCollection 2020. Front Immunol. 2020. PMID: 33424843 Free PMC article.

3

Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription.

Chen S, Su L, Qiu J, Xiao N, Lin J, Tan JH, Ou TM, Gu LQ, Huang ZS, Li D. Chen S, et al. Biochim Biophys Acta. 2013 Oct;1830(10):4769-77. doi: 10.1016/j.bbagen.2013.06.007. Epub 2013 Jun 14. Biochim Biophys Acta. 2013. PMID: 23774591

4

Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells.

Xiao N, Chen S, Ma Y, Qiu J, Tan JH, Ou TM, Gu LQ, Huang ZS, Li D. Xiao N, et al. Biochem Biophys Res Commun. 2012 Mar 16;419(3):567-72. doi: 10.1016/j.bbrc.2012.02.063. Epub 2012 Feb 17. Biochem Biophys Res Commun. 2012. PMID: 22369941

5

Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression.

Yan Q, Fang X, Liu X, Guo S, Chen S, Luo M, Lan P, Guan XY. Yan Q, et al. Adv Sci (Weinh). 2024 Jan;11(1):e2305653. doi: 10.1002/advs.202305653. Epub 2023 Nov 20. Adv Sci (Weinh). 2024. PMID: 37985644 Free PMC article.

6

A novel bispecific antibody, BiSS, with potent anti-cancer activities.

Dong B, Zhou C, He P, Li J, Chen S, Miao J, Li Q, Wang Z. Dong B, et al. Cancer Biol Ther. 2016 Apr 2;17(4):364-70. doi: 10.1080/15384047.2016.1139266. Epub 2016 Feb 1. Cancer Biol Ther. 2016. PMID: 26828900 Free PMC article.

7

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL.

Chen Y, Zhang Y, Chen S, Liu W, Lin Y, Zhang H, Yu F. Chen Y, et al. Pigment Cell Melanoma Res. 2022 Mar;35(2):238-251. doi: 10.1111/pcmr.13021. Epub 2021 Dec 14. Pigment Cell Melanoma Res. 2022. PMID: 34748282

8

LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer.

Li C, Chen S, Fang X, Du Y, Guan XY, Lin R, Xu L, Lan P, Yan Q. Li C, et al. Cell Biol Toxicol. 2024 Jan 25;40(1):6. doi: 10.1007/s10565-024-09840-1. Cell Biol Toxicol. 2024. PMID: 38267662 Free PMC article.

9

Bispecific antibodies in cancer immunotherapy.

Chen S, Li J, Li Q, Wang Z. Chen S, et al. Hum Vaccin Immunother. 2016 Oct 2;12(10):2491-2500. doi: 10.1080/21645515.2016.1187802. Epub 2016 Jun 1. Hum Vaccin Immunother. 2016. PMID: 27249163 Free PMC article. Review.

10

UHRF1 Controls Thymocyte Fate Decisions through the Epigenetic Regulation of EGR1 Expression.

Zhang Y, Chen Y, Ma R, Jiang Y, Liu J, Lin Y, Chen S, Xia M, Zou F, Zhang J, Pan T, Wang L, Wei L, Zhang H. Zhang Y, et al. J Immunol. 2020 Jun 15;204(12):3248-3261. doi: 10.4049/jimmunol.1901471. Epub 2020 May 1. J Immunol. 2020. PMID: 32358021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

575 results

Search Page